Published:October 17, 2020DOI:
        Erratum to: Carlsson A, Nair VS, Luttgen MS, et al. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. J Thorac Oncol. 2014;9:1111–1119.
        On page 1112 the “false discovery” rate of the National Lung Screening Trial was incorrectly referred to as the “false positive” rate.
        Please address all correspondence concerning this change to Anders Carlsson at [email protected] .

        Linked Article